Axl and Mertk Receptors Cooperate to Promote Breast Cancer Progression by Combined Oncogenic Signaling and Evasion of Host Antitumor Immunity

Despite the promising clinical benefit of targeted and immune checkpoint blocking therapeutics, current strategies have limited success in breast cancer, indicating that additional inhibitory pathways are required to complement existing therapeutics. TAM receptors (Tyro-3, Axl, and Mertk) are often...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer research (Chicago, Ill.) Ill.), 2021-02, Vol.81 (3), p.698-712
Hauptverfasser: Davra, Viralkumar, Kumar, Sushil, Geng, Ke, Calianese, David, Mehta, Dhriti, Gadiyar, Varsha, Kasikara, Canan, Lahey, Kevin C, Chang, Yun-Juan, Wichroski, Michael, Gao, Chan, De Lorenzo, Mariana S, Kotenko, Sergei V, Bergsbaken, Tessa, Mishra, Pankaj K, Gause, William C, Quigley, Michael, Spires, Thomas E, Birge, Raymond B
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!